Coronary Heart Disease Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Coronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Not Applicable
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
Premature Coronary Heart Disease
China National Center for Cardiovascular Diseases4,900 enrolled16 locationsNCT07031531